Nanospectra Biosciences Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Nanospectra Biosciences's estimated annual revenue is currently $3.5M per year.(i)
  • Nanospectra Biosciences's estimated revenue per employee is $875,000

Employee Data

  • Nanospectra Biosciences has 4 Employees.(i)
  • Nanospectra Biosciences grew their employee count by 100% last year.

Nanospectra Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
COO & VP, Process Development & ChemistryReveal Email/Phone
3
Dir ClinicalResearchReveal Email/Phone
4
Operations AdministratorReveal Email/Phone
5
Member Board Directors, Strategic ConsultantReveal Email/Phone
6
Senior Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.6M45543%N/AN/A
#2
$57.7M1385%N/AN/A
#3
$16.4M4841%N/AN/A
#4
$15M5333%N/AN/A
#5
$18.1M538%N/AN/A
#6
$7.5M1136%N/AN/A
#7
$42.2M11139%N/AN/A
#8
$7.5M65-2%N/AN/A
#9
$1M12-29%N/AN/A
#10
$8.2M27125%N/AN/A
Add Company

What Is Nanospectra Biosciences?

Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation. AuroLase, the company's lead product for the ablation of prostate cancer tissue, is the first and only ultra-focal tissue ablation therapy designed to maximize treatment efficacy while minimizing side effects typically associated with surgery, radiation, and traditional focal therapies. Implementing a multi-prong growth strategy, Nanospectra is focusing on clinical advancements, exclusive partnering agreements and ongoing research and development. Nanospectra’s technology development has been funded to date by a series of grants, private equity investments and corporate partnerships.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$3.5M

Revenue (est)

100%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M40%N/A
#2
$0.3M4-43%N/A
#3
$0.3M4N/AN/A
#4
$0.4M4N/AN/A
#5
$0.3M4N/AN/A